At Immunomedics, we created an integrated Patient Advocacy and Patient Experience function that allows us to develop comprehensive and cohesive programs and services built around the needs of people living with and affected by cancer. Our goal is to always view the “whole person” and help support their “mind, body, and soul.”
Our work and our engagement are guided by the following core principles:
|We squarely center our work on supporting the patient journey in authentic ways that give voice and dignity to individuals|
|We seek to build transparent, long-term relationships with advocacy groups that serve the cancer community|
|We are collaborative, as we recognize that we can collectively achieve more together than alone|
|We respect the independence of advocacy groups and their vital role as champions for people with cancer|
|We commit to continually listen and learn as we strive to transform the lives of people with cancer|
We are inspired by the efforts of our advocacy partners and are thankful for their trust in us and our continued partnership. We always aim to bring original and thoughtful ideas and dialogue that contribute to our advocacy partners in a way that continually enriches the perspectives and lives of patients and their caregivers.
The FDA approval of our first ADC therapy is our most prominent example of how we are delivering on our mission for all stakeholders: the triple-negative breast cancer (TNBC) community, our employees at Immunomedics, our stockholders, and our business partners and stakeholders.